News/ News/ R&D Lixiana hits the mark in catheter ablation trial Phil Taylor atrial fibrillation, catheter ablation, Daiichi Sankyo, Edoxaban, Lixiana 0 Comment Daiichi Sankyo’s Lixiana was a late entrant to the novel oral anticoagulant (NOAC) category, but the Japanese drugmaker Share X Lixiana hits the mark in catheter ablation trial https://pharmaphorum.com/news/lixiana-hits-the-mark-in-catheter-ablation-trial/
atrial fibrillation, catheter ablation, Daiichi Sankyo, Edoxaban, Lixiana
0 Comment
